Table 2.
Spearman rank correlation coefficients for the unadjusted association between maternal and amniotic fluid testosterone levels and maternal and fetal factors.
Study population I maternal serum testosterone | Study population II female fetus amniotic fluid testosterone | |||||||
---|---|---|---|---|---|---|---|---|
Total testosterone | Bioavailable testosterone | Total testosterone | ||||||
Variable | n | Spearman’s Rho | P | Spearman’s Rho | P | n | Spearman’s Rho | P |
Maternal age | 216 | −0.31 | 0.001 | −0.25 | 0.001 | 56 | −0.53 | 0.001 |
Maternal BMI first antenatal visit | 210 | 0.17 | 0.017 | 0.24 | 0001 | 56 | 0.22 | 0.1 |
Maternal weight gain last visit | 150 | 0.25 | 0.001 | 0.24 | 0.003 | 50 | 0.19 | 0.2 |
Gestational age | 216 | 0.05 | 0.4 | 0.06 | 0.4 | 56 | 0.32 | 0.018 |
EPDS score gestational week 17 | 207 | 0.23 | 0.001 | 0.18 | 0.008 | 56 | 0.16 | 0.3 |
EPDS score gestational week 32 | 213 | 0.27 | 0.001 | 0.20 | 0.004 | 54 | 0.02 | 0.9 |
Amniotic fluid cortisol | – | – | 56 | 0.56 | 0.001 |
EPDS, Edinburgh Postnatal Depression Scale.